Prevention of abnormal scarring in woundhealing

S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention

of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Unidirectional imaging technology breakthrough

UCLA researchers developed unidirectional imaging technology, a crucial capability for applications requiring asymmetric visual information processing and optical communication. Traditional imaging systems are bidirectional—if I can see you, you can…

Implantable microparticles can deliver two cancer therapies at once

The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors. Patients with late-stage cancer often have to endure multiple rounds of different types of…

Researchers Aim To Get Leg Up on Bone Repair with 3D-Printed Femur

University of Texas at Dallas mechanical engineers have designed a 3D-printed femur that could help doctors prepare for surgeries to repair bones and develop treatments for bone tumors. The engineers,…